Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
about
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanomaTamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsA clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanomaA phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma.Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.Treatment of malignant melanoma.Malignant melanoma (metastatic)Melanoma: a model for testing new agents in combination therapies.Metastatic melanoma: chemotherapy to biochemotherapy.The history and future of chemotherapy for melanoma.Meta-analysis of vascular and neoplastic events associated with tamoxifenA randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)Chemotherapy in the management of advanced cutaneous malignant melanoma.Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors.Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.Outpatient combination chemoimmunotherapy for patients with metastatic melanoma. Results of a phase I/II trial.High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma.Interferon-alpha and chemohormonal therapy for patients with advanced melanoma: final results of a phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program.Advances in management of melanoma.Malignant melanoma (metastatic).
P2860
Q26996629-F962F26E-55C4-4A6F-A8A5-CFF2432DA88EQ28084270-E48C24B9-CC96-49F9-8AD7-2337681012EBQ28369240-1F09E961-1A8F-4FCF-8BF5-3C26A3909A6AQ33357549-E0FB9E66-3B03-45A3-AE6A-42D2D4F89882Q33502404-8B91413F-FE58-425A-A709-2FBD4DAECAC8Q33689227-12D5EF33-3195-41EF-A388-0329EB045616Q33850507-58BD3A5C-2394-4F4E-A4EE-EAA06F7107E4Q33863916-8EAB5021-888F-4E11-AE81-EBB6F6442BA6Q34573040-A588A925-CFB4-44C4-85A0-AB467905BE9DQ34608084-F2FC2BBE-5507-456A-972D-BBCFD4EF5EB8Q34742590-3784D643-9DBA-48BF-A606-78CF50BE510AQ36621278-B6FF1D56-1A41-4F7E-A4E2-5D40DD8E8BB0Q36641817-10D946B7-30EF-4D25-B6F0-D8EB6F5E00A5Q36643649-703AC3B4-5095-4159-AFC1-2F1259D29BD3Q37007984-E85EF008-25B9-4C88-B919-D30FF0DB9CA4Q38019011-44DFE4D9-629D-4F21-B58D-EABEE234447CQ38088409-EF46A396-4E18-47E2-BC66-13C3DE4FAC7DQ38754840-6B7D0221-12DB-4912-A841-7A4C1F08FBD9Q41703695-6164D065-3103-4B88-850B-4594F5326EF8Q43707361-8D310564-66E1-4EB3-8654-AF7B5E0BA431Q45111202-8C0142F9-C37C-4123-80B2-98C5B7318D69Q47590210-6D41F863-C5BA-4CB0-98E5-DE4259EC4C26Q55549078-5F06A664-5F87-4F07-828E-5BAC49AA0119
P2860
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Randomized, double-blind, plac ...... Canada Clinical Trials Group.
@ast
Randomized, double-blind, plac ...... Canada Clinical Trials Group.
@en
type
label
Randomized, double-blind, plac ...... Canada Clinical Trials Group.
@ast
Randomized, double-blind, plac ...... Canada Clinical Trials Group.
@en
prefLabel
Randomized, double-blind, plac ...... Canada Clinical Trials Group.
@ast
Randomized, double-blind, plac ...... Canada Clinical Trials Group.
@en
P2093
P1476
Randomized, double-blind, plac ...... f Canada Clinical Trials Group
@en
P2093
A J Bodurtha
G R Armitage
H K Silver
J J Rusthoven
P B McCulloch
P304
P356
10.1200/JCO.1996.14.7.2083
P407
P577
1996-07-01T00:00:00Z